Gene · 406957
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targetome-defined miR-181c signaling from extracellular vesicles governs periodontal MSC fate via RNF150-MAP3K5. | Cell Commun Signal | 2026 | 42778936 | PubTator, text mining | PubMed |
| mi-RNA-mRNA Alterations in Sorted T-Cells of Acquired Aplastic Anemia: Validating the Observations of a Pilot Study. | Int J Lab Hematol | 2026 | 42604788 | PubTator, text mining | PubMed |
| MicroRNA-181 influences Alzheimer's risk by regulating neprilysin and microtubule-associated tau pathways, offering a novel target. | bioRxiv | 2026 | 42368021 | PubTator, text mining | PubMed |
| Plasma MicroRNA and Protein Signature Associated with Obesity in the Chinese Han Population Using MicroRNA Omics and Proteomics Analysis of 1026 Subjects. | Phenomics | 2026 | 42238038 | PubTator, text mining | PubMed |
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Plant-Derived Nanovesicles as Cell-Free Therapies for Thermal Burn Healing: A Systematic Review of Preclinical Evidence and Delivery Strategies. | Med Sci (Basel) | 2026 | 42201032 | PubTator, text mining | PubMed |
| Urinary Exosomal miRNAs as Non-Invasive Biomarkers Linked to Podocyte Morphometry in CKD. | Cells | 2026 | 41972684 | PubTator, text mining | PubMed |
| Mitochondrial miRNA- miR-181c-5p and mitomiR-106a-5p levels as indicators in cardiovascular disease patients. | Mol Biol Rep | 2026 | 41880039 | PubTator, text mining | PubMed |
| Evaluation of genetic variation in tumor suppressor miRNA encoding and their target genes in breast cancer; focus on miRNA interaction and expression analysis. | Front Genome Ed | 2026 | 41836053 | PubTator, text mining | PubMed |
| MicroRNA as Potential Biomarkers and Their Pathogenesis in Multiple System Atrophy. | Int J Mol Sci | 2026 | 41752011 | PubTator, text mining | PubMed |
| MicroRNAs in Long COVID: Key Regulators, Biomarkers, and Therapeutic Targets of Post-SARS-CoV-2 Sequelae. | Biomolecules | 2026 | 41750353 | PubTator, text mining | PubMed |
| From Bench to Bedside: Advancements in Precision Oncology and Drug Discovery for Osteosarcoma. | Cancers (Basel) | 2026 | 41749815 | PubTator, text mining | PubMed |
| Engineering Mitochondrial Biogenesis in iPSC-CMs: CRISPR-Guided Approaches for Advanced Cardiomyocyte Development. | J Cardiovasc Dev Dis | 2026 | 41745325 | PubTator, text mining | PubMed |
| Research progress on mitochondria in bone defect repair: mechanisms and therapeutic implications. | Front Bioeng Biotechnol | 2026 | 41725955 | PubTator, text mining | PubMed |
| Deregulation of Synaptic Plasticity-Related MicroRNAs After Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease. | Mol Neurobiol | 2026 | 41699353 | PubTator, text mining | PubMed |
Cell-free therapeutics for non-healing wounds: role of MSC-derived exosomes in macrophage polarization, angiogenesis, and fibroblast-mediated ECM remodeling-bridging preclinical insights to clinical translation. | Inflammopharmacology | 2026 | 41663771 | PubTator, text mining | PubMed |
| Extracellular vesicle-derived miR-760 as a novel promising candidate biomarker differentiating stable RRMS from SPMS. | Sci Rep | 2026 | 41535347 | PubTator, text mining | PubMed |
| Recent advances in the application of engineered extracellular vesicles from mesenchymal stem cells for traumatic central nervous system. | Eur J Pharmacol | 2026 | 41520759 | PubTator, text mining | PubMed |
| Mechanisms of microRNA trafficking to mitochondria in the heart. | Curr Opin Physiol | 2025 | 41624380 | PubTator, text mining | PubMed |
| Utility of microRNAs in Exhaled Breath Condensate as Diagnostic Biomarkers to Differentiate Pulmonary Sarcoidosis from Pulmonary Tuberculosis. | Sarcoidosis Vasc Diffuse Lung Dis | 2025 | 41396116 | PubTator, text mining | PubMed |
| Cardiac Circular RNAs CDR1as, Circ-RCAN2, Circ-C12orf29 Show Cell-Specific Hypoxia-Induced Dysregulation and Distinct In Vitro Effects. | Int J Mol Sci | 2025 | 41226374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406957/papers